Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in CD73 inhibitors for immunotherapy: Antibodies, synthetic small molecule compounds, and natural compounds
Mingxue Zhang, Xiaoqin Dai, Yu Xiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115546-115546
Closed Access | Times Cited: 10

Showing 10 citing articles:

Regulatory role of CD39 and CD73 in tumor immunity
Nicole Kaplinsky, K E Williams, Dean Watkins, et al.
Future Oncology (2024) Vol. 20, Iss. 19, pp. 1367-1380
Open Access | Times Cited: 7
Mechanistic role of quercetin as inhibitor for adenosine deaminase enzyme in rheumatoid arthritis: systematic review
Amira Atta, Maha M. Salem, Karim Samy El-Said, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Development of CD73 Inhibitors in Tumor Immunotherapy and Opportunities in Imaging and Combination Therapy
Chunyang Bi, Jimmy S. Patel, Steven H. Liang
Journal of Medicinal Chemistry (2025)
Open Access
Small molecular CD73 inhibitors: Recent progress and future perspectives
Gong-hui Ge, Qiu-yin Wang, Zhen-hao Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116028-116028
Closed Access | Times Cited: 9
Inhibition of Soluble Epoxide Hydrolase by Cembranoid Diterpenes from Soft Coral Sinularia maxima: Enzyme Kinetics, Molecular Docking, and Molecular Dynamics
Nguyen Viet Phong, Nguyễn Phương Thảo, Le Ba Vinh, et al.
Marine Drugs (2024) Vol. 22, Iss. 8, pp. 373-373
Open Access | Times Cited: 3
Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 775-776
Open Access | Times Cited: 2
Comparative characterisation of an ecto‐5′‐nucleotidase (CD73) in non‐tumoral MCF10‐A breast cells and triple‐negative MDA‐MB‐231 breast cancer cells
Thaís Cristino Rocha-Vieira, Marco Antonio Lacerda‐Abreu, Luiz Fernando Carvalho‐Kelly, et al.
Cell Biology International (2024) Vol. 48, Iss. 9, pp. 1354-1363
Closed Access | Times Cited: 2
Ectonucleotidase activity driven by acid ectophosphatase in luminal A MCF‐7 breast cancer cells
Marco Antonio Lacerda‐Abreu, Bruna dos Santos Mendonça, Gabriela Nestal de Moraes, et al.
Cell Biology International (2024)
Closed Access | Times Cited: 1
Novel CD73 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 571-572
Closed Access
Design, synthesis and structure-activity relationship of malonic acid non-nucleoside derivatives as potent CD73 inhibitors
Cunjian Shi, Jingqi Dai, Longfeng Chang, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 112, pp. 129946-129946
Closed Access
Page 1

Scroll to top